Back to
JACOBS LEVY EQUITY MANAGEMENT, INC
RAREShowing 7 of 20 quarters
Position history for
JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in ULTRAGENYX PHARMACEUTICAL IN
JACOBS LEVY EQUITY MANAGEMENT, INC holds 1.4M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $30M as of 2026-Q1. The position was decreased (-18.2% shares). RARE represents 0.1% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.
Current Value
$30M
Current Shares
1.4M
Total Value Change
+$3.9M
Total Shares Change
+796,744
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.